Regenxbio Inc
(FRA:RB0)
€
7.05
0 (0%)
Market Cap: 350.57 Mil
Enterprise Value: 186.24 Mil
PE Ratio: 0
PB Ratio: 1.29
GF Score: 59/100 Regenxbio Inc at Barclays Global Healthcare Conference Transcript
Mar 11, 2020 / 06:35PM GMT
Release Date Price:
€31.4
(-3.86%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst
Hello.
Kenneth T. Mills
REGENXBIO Inc. - CEO, President & Director
Hi.
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst
Okay, sorry. I think the music was a little bit longer than we thought. I'm sorry about -- everyone, we are a few minutes late. My name is Gena Wang. I'm mid-cap biotech analyst at the Barclays. I first hope everyone stay healthy and would like to thank all the participants, investors, companies and especially our event team and corporate access team who made this virtual healthcare conference possible.
With that, I would like to introduce our next speaker, Ken Mills, President and CEO from REGENXBIO. Ken, I will hand over to you.
Kenneth T. Mills
REGENXBIO Inc. - CEO, President & Director
Great. Thanks, Gena. And thanks, everyone, who's able to join and listen in today. I'll echo Gena's comments about keeping everyone well and safe. And also
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot